Most radiologists surveyed by the Society for Radiologists in Ultrasound said they perform more than 10 thyroid aspirations each week. But few used consistent criteria to determine which nodules were chosen for aspiration. Institutions performing more thyroid aspirations seem to find more malignant nodules, but the survey didn’t determine if this was a result of better methodology or simply a matter of patient selection.
Most radiologists surveyed by the Society for Radiologists in Ultrasound said they perform more than 10 thyroid aspirations each week. But few used consistent criteria to determine which nodules were chosen for aspiration. Institutions performing more thyroid aspirations seem to find more malignant nodules, but the survey didn't determine if this was a result of better methodology or simply a matter of patient selection.
Dr. Roberta diFlorio-Alexander, a radiologist at Dartmouth-Hitchcock Medical Center in New Hampshire, presented results of the survey distributed by the SRU to its fellows at the 2006 RSNA meeting. Radiologists answered questions about volume of thyroid procedures, criteria used for choosing which thyroid nodules would be aspirated, procedural methods such as needle size preference, and incidence of cytopathology.
Roughly half of the 46 respondents said they routinely biopsied multiple thyroid nodules on each patient. Ultrasound is unable to diagnose malignancy, but certain characteristics are considered suspicious, and these criteria are used in deciding which nodules to biopsy. The size of a nodule, for instance, can be determined with ultrasound, and this is a common criterion, but size has never been shown to be an indication of cytopathology. Microcalcifications were another common criterion used, along with other sonographic features unusual for thyroid tissue.
Slightly more than half of the biopsies using these criteria found cytopathology present in slightly more than half the nodules aspirated. Twenty-five percent of the rest had nondiagnostic results. Malignancy rates in thyroid aspirates ranged between 5% and 20%.
Variations in criteria used may account for some of the variability in results. A consensus statement published by the SRU in 2005 attempted to standardize the criteria. Among the consensus panel's conclusions:
Specific recommendations appear in chart form, and the full text of the report is available.
The recommendations allow physicians some flexibility in the selection of which nodules require fine-needle aspiration. The decision to perform or defer ultrasound-guided fine-needle aspiration for a particular thyroid nodule in a given patient should be made by the physician according to the individual circumstances.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.